Ionis Pharmaceuticals, Inc. · NASDAQ:IONS

T. Rowe Price Investment Management, Inc. reported a 10.00% stake in Ionis Pharmaceuticals, Inc. (Schedule 13G/A)

Event Jan 31, 2025 · Filed Feb 7, 2025

T. Rowe Price Investment Management, Inc. reported a 10.00% stake in Ionis Pharmaceuticals, Inc., 15,851,863 shares, as a passive investor on Jan 31, 2025. Filed Feb 7, 2025 (Schedule 13G/A).

Stake
10.00%
Shares
15,851,863
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
T. Rowe Price Investment Management, Inc.10.00%15,851,863

Source

View original at SEC

Related